PODZY-CV 50 DRY SYRUP

COMPOSITION: - CEFPODOXIME PROXETIL 50 MG & POTASSUIM CLAVULANATE ORAL 31.25 MG SUSPENSION

PACKING: - 4GM/30ML

M.R.P: - 115

PHARMACOKINETICS

CEFPODOXIME PROXETIL

• Absorption: - De-esterification of Cefpodoxime Proxetil takes place in the gastrointestinal tract where it is absorbed and is converted to its active metabolite which is Cefpodoxime.
• Metabolism: - It gets metabolised in-vivo.
• Excretion: - Through urine.

POTASSUIM CLAVULANATE

Absorption: - Potassium Clavulanate is well absorbed from the gastro-intestinal tract.

INDICATIONS: -

• Respiratory infection
• Urinary tract infections
• Uncomplicated skin infections